-
公开(公告)号：US09540323B2
公开(公告)日：2017-01-10
申请号：US14418023
申请日：2013-07-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Alexandre L'Heureux , Sheldon Hiebert , Carol Hu , Patrick Y. S. Lam , John Lloyd , Zulan Pi , Jennifer X. Qiao , Carl Thibeault , George O. Tora , Wu Yang , Yufeng Wang , Tammy C. Wang , Michael S. Bowsher , Ruel Rejean
IPC: C07D209/26 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/14 , C07D409/04 , C07D413/04 , C07D417/12 , C07D417/14 , C07D471/04 , C07D498/04 , C07D209/14 , C07D513/04 , C07D403/12 , C07D413/14 , C07D417/04
CPC classification number: C07D209/26 , C07D209/14 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
Abstract: The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义的式（I）和包含任何这些新化合物的组合物。 这些化合物是可以使用药物的P2Y1受体的拮抗剂。
-
公开(公告)号：US09527885B2
公开(公告)日：2016-12-27
申请号：US14592313
申请日：2015-01-08
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Sheldon Hiebert , Ramkumar Rajamani , Li-Qiang Sun , Eric Mull , Eric P. Gillis , Michael S. Bowsher , Qian Zhao , Nicholas A. Meanwell , Kishore V. Renduchintala , Kandhasamy Sarkunam , Pulicharla Nagalakshmi , P.V.K. Suresh Babu , Paul Michael Scola
IPC: C07D225/02 , C07K5/097 , C07D487/04 , C07K5/083 , C07K5/08 , A61K38/20 , A61K38/21 , A61K45/06 , A61K31/13 , A61K31/4745 , A61K31/7056 , A61K38/06 , A61K38/00
CPC classification number: C07K5/0823 , A61K31/13 , A61K31/4745 , A61K31/7056 , A61K38/00 , A61K38/06 , A61K38/2013 , A61K38/204 , A61K38/2053 , A61K38/21 , A61K38/212 , A61K45/06 , C07D487/04 , C07K5/0804 , C07K5/0827 , A61K2300/00
Abstract: Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
-
公开(公告)号：US20150259286A1
公开(公告)日：2015-09-17
申请号：US14418023
申请日：2013-07-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Alexandre L'Heureux , Sheldon Hiebert , Carol Hu , Patrick Y.S. Lam , John Lloyd , Zulan Pi , Jennifer X. Qiao , Carl Thibeault , George O. Tora , Wu Yang , Yufeng Wang , Tammy C. Wang , Michael S. Bowsher , Ruel Rejean
IPC: C07D209/26 , C07D401/12 , C07D403/12 , C07D513/04 , C07D413/04 , C07D401/04 , C07D403/04 , C07D498/04 , C07D417/14 , C07D413/14 , C07D409/04 , C07D417/12 , C07D417/04
CPC classification number: C07D209/26 , C07D209/14 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
Abstract: The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义的式（I）和包含任何这些新化合物的组合物。 这些化合物是可以使用药物的P2Y1受体的拮抗剂。
-
公开(公告)号：US20150125422A1
公开(公告)日：2015-05-07
申请号：US14592313
申请日：2015-01-08
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Sheldon Hiebert , Ramkumar Rajamani , Li-Qiang Sun , Eric Mull , Eric P. Gillis , Michael S. Bowsher , Qian Zhao , Nicholas A. Meanwell , Kishore V. Renduchintala , Kandhasamy Sarkunam , Pulicharla Nagalakshmi , P.V.K. Suresh Babu , Paul Michael Scola
CPC classification number: C07K5/0823 , A61K31/13 , A61K31/4745 , A61K31/7056 , A61K38/00 , A61K38/06 , A61K38/2013 , A61K38/204 , A61K38/2053 , A61K38/21 , A61K38/212 , A61K45/06 , C07D487/04 , C07K5/0804 , C07K5/0827 , A61K2300/00
Abstract: Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
-
-
-
Search Results
4
records
(took 0.033 seconds)
